Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Qinlan Oral Liquid
- Development stage
- Unknown
- Lead developer
- Heilongjiang ZBD Pharmaceutical
- Administration
- Oral
01
Overview
Compound Qinlan Oral Liquid is a traditional Chinese medicine (TCM) formulation developed by Harbin Treasure Pharmaceutical. It is an oral liquid preparation typically composed of extracts from four primary medicinal herbs: *Scutellaria baicalensis* (Baical Skullcap), *Lonicera japonica* (Japanese Honeysuckle), *Forsythia suspensa* (Weeping Forsythia), and *Isatis tinctoria* (Woad Root). The formulation is designed to clear heat, detoxify, and disperse wind-heat, common therapeutic goals in TCM for treating respiratory ailments. While the product is widely used in China for general respiratory symptoms, Harbin Treasure Pharmaceutical is specifically developing and evaluating this formulation in Phase 2/3 clinical trials for the treatment of external wind-heat syndrome in children aged 4 to 12 years.
- Brand names
- Compound Qinlan Oral Liquid
- Other names
- 复方芩兰口服液Fufang Qinlan Koufuye
02
Targets
Mpro (3C-like proteinase of SARS-CoV-2)ACE2 (Angiotensin-converting enzyme 2)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IL-6 (Interleukin 6)TLR4 (Toll-like receptor 4)
Beyond the preview
Go deeper on Compound Qinlan Oral Liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Qinlan Oral Liquid.